Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garrett M Brodeur

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2017
The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking GlassDavid Malkin, Kim E Nichols, Joshua D Schiffman, et al.
Cancer|November 19, 2013
Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stagesMehrnaz Fatemi, Thomas A Paul, Garrett M Brodeur, et al.
Expert Opinion on Therapeutic Targets|January 7, 2014
Therapeutic targets for neuroblastomasGarrett M Brodeur, Radhika Iyer, Jamie L Croucher, et al.
Molecular Cancer|August 7, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastomaMayumi Higashi, Venkatadri Kolla, Radhika Iyer, et al.
Mechanisms of Development|November 21, 2013
CHD5 is required for spermiogenesis and chromatin condensationTiangang Zhuang, Rex A Hess, Venkatadri Kolla, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2011
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastomaRobin E Norris, Jane E Minturn, Garrett M Brodeur, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 19, 2019
Gastrointestinal Polyposis in Pediatric PatientsSuzanne P MacFarland, Kristin Zelley, Bryson W Katona, et al.
Human Mutation|September 9, 2014
Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart diseasePetra Werner, Prasuna Paluru, Anisha M Simpson, et al.
Cancer Research|March 26, 2002
Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cellsAngelika Eggert, Michael A Grotzer, Naohiko Ikegaki, et al.
The Biochemical Journal|April 1, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complexVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2017
The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking GlassDavid Malkin, Kim E Nichols, Joshua D Schiffman, et al.
Cancer|November 19, 2013
Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stagesMehrnaz Fatemi, Thomas A Paul, Garrett M Brodeur, et al.
Expert Opinion on Therapeutic Targets|January 7, 2014
Therapeutic targets for neuroblastomasGarrett M Brodeur, Radhika Iyer, Jamie L Croucher, et al.
Molecular Cancer|August 7, 2015
Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastomaMayumi Higashi, Venkatadri Kolla, Radhika Iyer, et al.
Mechanisms of Development|November 21, 2013
CHD5 is required for spermiogenesis and chromatin condensationTiangang Zhuang, Rex A Hess, Venkatadri Kolla, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2011
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastomaRobin E Norris, Jane E Minturn, Garrett M Brodeur, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 19, 2019
Gastrointestinal Polyposis in Pediatric PatientsSuzanne P MacFarland, Kristin Zelley, Bryson W Katona, et al.
Human Mutation|September 9, 2014
Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart diseasePetra Werner, Prasuna Paluru, Anisha M Simpson, et al.
Cancer Research|March 26, 2002
Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cellsAngelika Eggert, Michael A Grotzer, Naohiko Ikegaki, et al.
The Biochemical Journal|April 1, 2015
The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complexVenkatadri Kolla, Koumudi Naraparaju, Tiangang Zhuang, et al.
Pageof 9